Avid Bioservices Inc $ 7.73 0.06 (0.78%)
Volume:
415,819
Avg Vol (1m):
427,081
Market Cap $:
436.83 Mil
Enterprise Value $:
423.04 Mil
P/E (TTM):
0.00
P/B:
10.42
Financial Strength | 3/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 1.61 | ||
| Equity-to-Asset | 0.39 | ||
| Debt-to-Equity | 0.54 | ||
| Debt-to-EBITDA | -3 | ||
| Piotroski F-Score | 3 | ||
| Altman Z-Score | -3.04 | ||
| Beneish M-Score | -3.03 | ||
| WACC vs ROIC | |||
Profitability Rank | 1/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | -17.73 | ||
| Net Margin % | -17.53 | ||
| ROE % | -32.95 | ||
| ROA % | -10.5 | ||
| ROC (Joel Greenblatt) % | -24.33 | ||
| 3-Year Revenue Growth Rate | -12 | ||
| 3-Year EPS without NRI Growth Rate | -44.2 |
Valuation Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PB Ratio | 10.42 | ||
| PS Ratio | 7.29 | ||
| Price-to-Free-Cash-Flow | 214.72 | ||
| Price-to-Operating-Cash-Flow | 74.33 | ||
| EV-to-EBIT | -39.97 | ||
| EV-to-EBITDA | -56.45 | ||
| EV-to-Revenue | 7.09 | ||
| Current Ratio | 1.34 | ||
| Quick Ratio | 1.1 | ||
| Days Inventory | 56.08 | ||
| Days Sales Outstanding | 52.61 | ||
| Days Payable | 38.78 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8.7 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 10.45 | ||
| Price-to-Median-PS-Value | 1.3 | ||
| Earnings Yield (Greenblatt) % | -2.5 |